Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Mitochondrial antiviral signaling protein (MAVS) acts as an adaptor protein and plays an important role in regulating the host's natural immune signaling pathway. Cell pattern recognition receptors such as Toll-like receptors (TLRs) and RIG-I-like receptors (RLRs) recognize invading pathogens and transmit signals to MAVS, which activate NF- by stimulating downstream TBK1 complexes and IKK complexes, respectively. Signaling pathways such as κB and IRF3 activate interferon α/β expression and induce intracellular anti-infective natural immune responses. In addition to localizing mitochondria, MAVS can also be localized to peroxisomes. The different localization of MAVS in cells determines its different regulatory mechanisms in early rapid and sustained antiviral innate immunity.
MAVS is a classic "tail-anchored" membrane protein whose C-terminal transmembrane domain (TM) anchors MAVS to many organelle membrane surfaces, such as mitochondria, peroxisomes, and sub-domains of the endoplasmic reticulum (MAM). The different localization of MAVS mitochondria and peroxisomes determines their specificity in innate immune regulation. Peroxisome MAVS can trigger rapid, transient, and unstable expression of interferon-stimulated genes (ISGs). Mitochondrial MAVS can induce delayed and stable expression of ISG, so wild-type MAVS can induce rapid and stable expression of ISG.

Figure 1. Inflammatory mitochondrial dysfunction and oxidative stress initiate further inflammatory responses and apoptosis through inflammasome activation. (Zorzano, et al. 2015)
MAVS Function
MAVS plays a central role in the mediated innate antiviral response. Taking the RIG-I signaling pathway as an example, the E3 ubiquitin ligase Riplet and TRIM25 play a key role in their recognition of RNA and activation. RIG-I is activated by ubiquitination of K63 mediated by Riplet and TRIM25 (tripartite motif containing protein 25). After RIG-I multimerization, it forms a complex with TRIM25 and chaperone 14-3-3ε. The complex is called "translocon", which is transported from the cytoplasm to the inner membrane of the cell, such as mitochondrion-associated membrane (MAM) and MAVS.
MAVS is localized in different subcellular structures, and MAVS may anchor to different organelle membranes by recognizing specific lipids or proteins on the membrane to exert its antiviral function. This membrane localization property of MAVS is essential for its antiviral activity, and the MAVS transmembrane domain is removed to lose its antiviral activity. In the expression of MAVS mutant (miniMAVS) containing only the CARD domain and the TM domain, MAVS-mediated signaling can still be induced, and miniMAVS can maintain the functional properties of MAVS mitochondrial localization, oligomerization, and CARD domain adsorption. This helicase domain and C-terminal binding domain (CTD) of MAVS are essential structures for the recognition of viral RNA and activation of downstream signaling pathways.
Viral Digestion of MAVS
NS3/4A is a serine protease encoded by hepatitis C virus, which cleaves cysteine at position 508 of MAVS, and cleaves MAVS into two molecules of different sizes, making it unable to localize to mitochondria and destroy its oligomerization. The function of the downstream signal is activated to block the RLR-mediated signaling pathway. In addition to hepatitis C virus-encoded NS3/4A, hepatitis A virus-encoded 3ABC (a precursor of 3Cpro cysteinyl protease) and a hepatitis B virus-encoded X protein, HBX, cleave MAVS to block signal transduction. The study found that human coronavirus NL63 PLP protease disrupts the MAVSSTING-TBK1/IKKε complex, blocks the function of MAVS and STING in the antiviral innate immune signaling pathway, and negatively regulates host antiviral innate immunity, thereby revealing another new mechanism by which papa-like protease PLP regulates host antiviral innate immunity.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.